[ad_1]
Health
Reuters
The results of a small trial in Hong Kong indicated that a combination of three antivirals helped alleviate symptoms in people with mild to moderate cases of Covid-19 disease.
This trial, which included 12 patients, compared those receiving the combination of lupinavir / ritonavir to treat HIV and ribavirin to treat hepatitis C and interferon beta to treat multiple sclerosis, and a control group that received a deficiency medication Only acquired immunity.
The results showed that the people who received the combined drug reached the point of not detecting the virus in their bodies five days earlier than the participants in the control group, that is, seven days versus 12 days.
“Our experience shows that initial treatment for Covid-19 cases, which ranged from mild to medium with antivirals, can accelerate virus suppression in the patient’s body, alleviate symptoms, and reduce risk for workers in Campo de health “.
He added that the reduced risk for health workers is due to the effect of this triple combination on the “viral test” that occurs when the virus can be discovered and the possibility of transmission.
Source: “Reuters”
[ad_2]
